Enhanc3D Genomics
Helen Bignell is an accomplished scientist with extensive experience in the field of biochemistry and molecular biology. Currently serving as Principal Scientist at Enhanc3D Genomics Ltd since October 2021, Bignell previously held the same title at Cambridge Epigenetix for over seven years. Prior experience includes roles as Staff Scientist at Illumina and Scientist 3 at Solexa, along with earlier work as Research Assistant at The Binding Site. Helen earned a Bachelor's degree in Biochemistry from the University of Cambridge, followed by a Master of Philosophy (MPhil) and a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from the University of Birmingham.
This person is not in any offices
Enhanc3D Genomics
1 followers
Enhanc3D Genomics is a functional genomics firm that studies the three-dimensional organization of DNA in health and disease. The company's GenLink3D platform helps comprehend the impact of such mutations on distant genes, thereby revealing how they influence disease progression.